Clinical trials
Recruiting Phase 2 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
167 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 15 |
| 2024 | 17 |
| 2025 | 65 |
| 2026 | 54 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 167 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 14 |
| Eli Lilly and Company | 14 |
| Novartis Pharmaceuticals | 9 |
| Pfizer | 9 |
| AbbVie | 8 |
| Takeda | 8 |
| Boehringer Ingelheim | 7 |
| National Cancer Center, Japan | 7 |
| Merck Sharp & Dohme LLC | 6 |
| Ono Pharmaceutical Co., Ltd. | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Breast Neoplasms | 7 |
| Neoplasms | 7 |
| Colitis, Ulcerative | 6 |
| Ovarian Neoplasms | 6 |
| Urinary Bladder Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Alzheimer Disease | 4 |
| Endometrial Neoplasms | 4 |
Trials
Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.
67 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.